DoD's $35.2M Clinical Trial Support Contract Awarded to ICON Government and Public Health Solutions
Contract Overview
Contract Amount: $35,222,551 ($35.2M)
Contractor: Icon Government and Public Health Solutions, Inc.
Awarding Agency: Department of Defense
Start Date: 2011-09-26
End Date: 2021-05-26
Contract Duration: 3,530 days
Daily Burn Rate: $10.0K/day
Competition Type: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Number of Offers Received: 1
Pricing Type: COST PLUS FIXED FEE
Sector: R&D
Official Description: CLINICAL TRIAL SUPPORT
Place of Performance
Location: SILVER SPRING, MONTGOMERY County, MARYLAND, 20910
State: Maryland Government Spending
Plain-Language Summary
Department of Defense obligated $35.2 million to ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. for work described as: CLINICAL TRIAL SUPPORT Key points: 1. Contract awarded for Research and Development in Biotechnology. 2. ICON Government and Public Health Solutions, Inc. is the sole awardee. 3. The contract spans nearly 10 years, indicating a long-term need. 4. The contract type is Cost Plus Fixed Fee, which can lead to cost overruns if not managed carefully.
Value Assessment
Rating: fair
The contract's Cost Plus Fixed Fee structure requires careful monitoring to ensure costs remain reasonable. Benchmarking against similar R&D contracts is difficult without more detailed cost breakdowns.
Cost Per Unit: N/A
Competition Analysis
Competition Level: limited
The contract was awarded under 'FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES,' suggesting a limited competition scenario. This method may not have yielded the most competitive pricing.
Taxpayer Impact: The pricing structure and limited competition could potentially lead to higher costs for taxpayers compared to a fully open and competitive process.
Public Impact
Supports critical research and development in biotechnology. Long-term contract duration suggests ongoing government reliance on these services. Potential for innovation and advancement in public health through contracted research.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Cost Plus Fixed Fee contract type can incentivize higher spending.
- Limited competition may result in suboptimal pricing.
- Long contract duration increases exposure to potential cost escalations.
Positive Signals
- Supports vital R&D in biotechnology.
- Long-term engagement indicates a stable and important program.
Sector Analysis
This contract falls within the Research and Development sector, specifically Biotechnology. Spending in this area is crucial for scientific advancement but can be complex to benchmark due to unique project scopes and intellectual property considerations.
Small Business Impact
There is no indication that small businesses were involved in this contract, either as prime contractors or subcontractors. Further analysis would be needed to determine if opportunities were missed.
Oversight & Accountability
The Cost Plus Fixed Fee contract type necessitates robust oversight from the Department of the Army to manage costs effectively and ensure adherence to the fixed fee. Regular audits and performance reviews are critical.
Related Government Programs
- Research and Development in Biotechnology
- Department of Defense Contracting
- Department of the Army Programs
Risk Flags
- Cost Plus Fixed Fee contract type.
- Limited competition awarded.
- Long contract duration.
- Lack of small business participation.
Tags
research-and-development-in-biotechnolog, department-of-defense, md, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Defense awarded $35.2 million to ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.. CLINICAL TRIAL SUPPORT
Who is the contractor on this award?
The obligated recipient is ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC..
Which agency awarded this contract?
Awarding agency: Department of Defense (Department of the Army).
What is the total obligated amount?
The obligated amount is $35.2 million.
What is the period of performance?
Start: 2011-09-26. End: 2021-05-26.
What specific biotechnology research areas are covered under this contract, and how do they align with current DoD priorities?
The provided data does not specify the exact biotechnology research areas. However, given the Department of Defense's involvement, it likely pertains to areas such as biodefense, medical countermeasures, advanced diagnostics, or soldier performance enhancement. Alignment with DoD priorities would require a review of the contract's statement of work and strategic research objectives.
How does the 'FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES' process impact the overall value and cost-effectiveness of this contract?
This procurement method suggests that initial full and open competition may have occurred, but specific sources were later excluded, leading to a limited competition award. While potentially justified for specialized needs, it can reduce competitive pressure, potentially leading to higher prices and less innovation compared to a truly open competition. The value is thus contingent on the necessity of excluding certain bidders.
What are the key performance indicators (KPIs) used to measure the effectiveness of ICON Government and Public Health Solutions' support in this contract?
Key performance indicators for clinical trial support contracts typically include adherence to study protocols, data integrity, patient recruitment rates, timely reporting of results, and compliance with regulatory standards (e.g., FDA, GCP). The effectiveness of ICON's support would be measured against these metrics, ensuring the quality and reliability of the clinical trial outcomes.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in Biotechnology
Product/Service Code: RESEARCH AND DEVELOPMENT › General Science and Technology R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Solicitation ID: W81XWH11R0014
Offers Received: 1
Pricing Type: COST PLUS FIXED FEE (U)
Evaluated Preference: NONE
Contractor Details
Parent Company: Icon Public Limited Company
Address: 1265 RIDGE RD STE A, HINCKLEY, OH, 44233
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $37,564,235
Exercised Options: $37,564,235
Current Obligation: $35,222,551
Subaward Activity
Number of Subawards: 7
Total Subaward Amount: $1,631,794
Contract Characteristics
Multi-Year Contract: Yes
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: NO
Timeline
Start Date: 2011-09-26
Current End Date: 2021-05-26
Potential End Date: 2021-05-26 00:00:00
Last Modified: 2024-03-21
More Contracts from Icon Government and Public Health Solutions, Inc.
- Clinical Services Network- Clinical Trial Planning and Execution — $330.2M (Department of Health and Human Services)
- Labor - Base Year (3 Months) — $35.2M (Department of Defense)
- Clinical Trial Planning and Execution (ctpe) — $34.1M (Department of Health and Human Services)
- Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases — $24.4M (Department of Health and Human Services)
- Base Year Non-Personal Services — $20.8M (Department of Defense)
View all Icon Government and Public Health Solutions, Inc. federal contracts →
Other Department of Defense Contracts
- Federal Contract — $51.3B (Humana Government Business Inc)
- Lrip LOT 12 Advance Acquisition Contract — $35.1B (Lockheed Martin Corporation)
- SSN 802 and 803 Long Lead Time Material — $34.7B (Electric Boat Corporation)
- 200204!008532!1700!AF600 !naval AIR Systems Command !N0001902C3002 !A!N! !N! !20011026!20120430!008016958!008016958!834951691!n!lockheed Martin Corporation !lockheed Blvd !fort Worth !tx!76108!27000!439!48!fort Worth !tarrant !texas !+000026000000!n!n!018981928201!ac15!rdte/Aircraft-Eng/Manuf Develop !a1a!airframes and Spares !2ama!jast/Jsf !336411!E! !3! ! ! ! ! !99990909!B! ! !A! !a!n!r!2!002!n!1a!a!n!z! ! !N!C!N! ! ! !a!a!a!a!000!a!c!n! ! ! !Y! !N00019!0001! — $34.2B (Lockheed Martin Corporation)
- KC-X Modernization Program — $32.0B (THE Boeing Company)